AstraZeneca Can't Block Generic Nexium During Appeal
By Jonathan Randles ( September 13, 2013, 6:28 PM EDT) -- A New Jersey federal judge on Friday rejected AstraZeneca AB's bid to delay a generic version of its acid reflux drug Nexium manufactured by South Korea's Hanmi Pharmaceutical Co. Ltd. while AstraZeneca awaits the outcome of an appeal challenging a decision that hindered its patent infringement claims....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.